TOP2A and hepatocellular carcinoma: Consistent with these results, we observed a significant increase in H3K27me3 levels within the TOP2A promoter region following NCTD treatment, suggesting that the suppression of TOP2A expression by NCTD is mediated by the enrichment of repressive chromatin marked by H3K27me3 in HCC.